- Home
- SCLX vs VRAR Comparison
SCLX vs VRAR Comparison
Compare SCLX & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- VRAR
- Stock Information
- Founded
- SCLX 2011
- VRAR 2016
- Country
- SCLX United States
- VRAR United States
- Employees
- SCLX N/A
- VRAR N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- VRAR Retail: Computer Software & Peripheral Equipment
- Sector
- SCLX Health Care
- VRAR Technology
- Exchange
- SCLX Nasdaq
- VRAR Nasdaq
- Market Cap
- SCLX 35.7M
- VRAR 29.1M
- IPO Year
- SCLX N/A
- VRAR 2021
- Fundamental
- Price
- SCLX $18.73
- VRAR $1.63
- Analyst Decision
- SCLX Strong Buy
- VRAR Strong Buy
- Analyst Count
- SCLX 3
- VRAR 1
- Target Price
- SCLX $367.50
- VRAR $2.62
- AVG Volume (30 Days)
- SCLX 309.9K
- VRAR 315.5K
- Earning Date
- SCLX 08-13-2025
- VRAR 11-13-2025
- Dividend Yield
- SCLX N/A
- VRAR N/A
- EPS Growth
- SCLX N/A
- VRAR N/A
- EPS
- SCLX N/A
- VRAR N/A
- Revenue
- SCLX $44,236,000.00
- VRAR $10,527,925.00
- Revenue This Year
- SCLX $89.26
- VRAR $16.26
- Revenue Next Year
- SCLX $203.95
- VRAR $43.33
- P/E Ratio
- SCLX N/A
- VRAR N/A
- Revenue Growth
- SCLX N/A
- VRAR 19.58
- 52 Week Low
- SCLX $3.60
- VRAR $0.50
- 52 Week High
- SCLX $39.90
- VRAR $7.00
- Technical
- Relative Strength Index (RSI)
- SCLX 46.04
- VRAR 51.91
- Support Level
- SCLX $14.80
- VRAR $1.40
- Resistance Level
- SCLX $30.90
- VRAR $1.78
- Average True Range (ATR)
- SCLX 3.47
- VRAR 0.17
- MACD
- SCLX -1.47
- VRAR -0.00
- Stochastic Oscillator
- SCLX 23.68
- VRAR 48.83
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.